Excelsior Correspondent
JAMMU, May 30: To raise awareness about obesity and type 2 diabetes, Eli Lilly and Company (India) today announced partnership with Apollo Clinic, a prominent clinic network under Apollo Health and Lifestyle (AHLL) and Apollo Health Co. (Apollo 24|7), all part of larger Apollo Group.
This joint initiative will focus on boosting awareness and promoting appropriate healthcare solutions for obesity and type-2 diabetes nationwide.
Obesity, a chronic relapsing disease, is a major risk factor for diabetes, is linked to over 200 health complications, including hypertension, dyslipidemia, coronary heart disease and obstructive sleep apnea.
Adult obesity prevalence in India stood at around 6.5%, affecting nearly 100 million people.
Speaking on the occasion, Winselow Tucker, president and general manager, India said, “This partnership reflects our shared commitment to support people living with obesity and type-2 diabetes by increasing awareness around prevention and evidence-based management.”
He said, “Through this partnership, we aim to make a meaningful impact on how obesity and type-2 diabetes are understood and managed. Together, we’re working to improve awareness, support better outcomes, and empower individuals to take charge of their long-term health.”
Dr Sangita Reddy, joint managing director, AHLL said, “This collaboration marks the beginning of a long-term commitment to transforming obesity and type-2 diabetes care in India. Our yearly “Health of Nation” reports highlight a concerning trend: 49% of women and 55% of men under 40 are obese, a figure that drastically rises to 73% of women and 65% of men in the 40-55 age group. This alarming rise in obesity and physical inactivity, along with non-communicable diseases, remains undiagnosed and underscores the urgent need for action.”
“With significant solutions in the scientific realm for Obesity management in many of our hospitals, we are now committed to creating Centres of Excellence in Obesity Management. Such partnerships aim to develop a scalable & impactful model that can drive future healthcare initiatives and significantly improve patient outcomes across the country,” she added.
Follow our WhatsApp channel